Jinghang Xu
- Hepatology top 5%
- Hepatitis C virus research 17
- Liver Disease and Transplantation 9
- Liver physiology and pathology 2
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 28
- Hepatitis B Virus Studies 20
-
- MicroRNA in disease regulation 2
-
- Drug-Induced Hepatotoxicity and Protection 5
-
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Yanyan YuPing AnCheryl A. WinklerQiao ZhanZheng ZengXiaoyuan XuHani El‐NezamiShengliang Xin
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jinghang Xu
35 papers receiving 447 citations
Peers
Comparison fields: 5 of 73
- Hepatology 223
- Epidemiology 298
- Cancer Research 78
- Immunology 42
- Molecular Biology 123
Countries citing papers authored by Jinghang Xu
This map shows the geographic impact of Jinghang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinghang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinghang Xu more than expected).
Fields of papers citing papers by Jinghang Xu
This network shows the impact of papers produced by Jinghang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinghang Xu. The network helps show where Jinghang Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinghang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 0 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 25 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 65 | |
| 14 | 2020 | 50 | |
| 15 | 2020 | 10 | |
| 16 | 2018 | 102 | |
| 17 | 2016 | 4 | |
| 18 | 2013 | 10 | |
| 19 | 2012 | 1 | |
| 20 | 2009 | 33 |
About Jinghang Xu
Jinghang Xu is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 38 papers that have together received 452 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (28 papers), Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (17 papers), Liver Disease and Transplantation (9 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Viral gastroenteritis research and epidemiology (2 papers), Liver physiology and pathology (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Hepatology (223 citations), Epidemiology (298 citations) and Cancer Research (78 citations). Jinghang Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yanyan Yu, Ping An, Cheryl A. Winkler, Qiao Zhan, Zheng Zeng, Xiaoyuan Xu, Hani El‐Nezami, Shengliang Xin, Ying Han and Hui Zhuang. Their work appears in journals such as PLoS ONE, IEEE Access and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.